Treatment Protocol for Conjunctivitis
Bacterial Conjunctivitis
For mild to moderate bacterial conjunctivitis, prescribe a 5-7 day course of broad-spectrum topical antibiotic applied 4 times daily, which accelerates clinical resolution, reduces transmissibility, and allows earlier return to school or work. 1
First-Line Antibiotic Selection
Choose the most convenient or least expensive broad-spectrum topical antibiotic for mild cases, as no clinical evidence demonstrates superiority of any particular agent 1
Acceptable first-line options include:
Reserve fluoroquinolones (moxifloxacin, gatifloxacin, levofloxacin, ciprofloxacin, besifloxacin) for moderate to severe cases with copious purulent discharge, pain, and marked inflammation, or when resistant organisms are suspected 1
Contact lens wearers require fluoroquinolone coverage due to higher risk of Pseudomonas infection 1
Dosing Regimens
- Standard regimen: Apply topical antibiotic 4 times daily for 5-7 days 1, 2
- Moxifloxacin 0.5%: Instill one drop in affected eye 3 times daily for 7 days 3
- Moxifloxacin demonstrates clinical cure rates of 66-69% by Day 5-6 and microbiological eradication rates of 84-94% 3
Moderate to Severe Bacterial Conjunctivitis
- Obtain conjunctival cultures and Gram staining before initiating treatment if severe purulent discharge is present or gonococcal infection is suspected 1
- Consider brief course of topical corticosteroids if severe inflammation of conjunctiva or eyelid is present, with baseline and periodic intraocular pressure monitoring 1
Follow-Up Protocol
- Advise patients to return in 3-4 days if no improvement is noted 4, 1
- At follow-up, perform interval history, visual acuity measurement, and slit-lamp biomicroscopy 1
- If no improvement after 3-4 days, consider alternative diagnoses, resistant organisms (particularly MRSA), or need for culture 1
Special Bacterial Conjunctivitis Scenarios
Gonococcal Conjunctivitis
Gonococcal conjunctivitis requires systemic antibiotic therapy in addition to topical treatment, as topical antibiotics alone are inadequate. 1
- Systemic treatment: Ceftriaxone 125 mg IM single dose (for patients ≥45 kg) 2
- Add saline lavage to promote comfort and faster resolution of inflammation 1
- Daily follow-up is mandatory until resolution 2
- Hospitalization may be necessary for severe cases 1
- Always consider and evaluate for sexual abuse in children with gonococcal conjunctivitis 2
- Treat sexual partners simultaneously 4
Chlamydial Conjunctivitis
Chlamydial conjunctivitis requires systemic antibiotic therapy, as more than 50% of infants may have infection at other sites (nasopharynx, genital tract, lungs). 4
- Systemic treatment options (for patients ≥8 years):
- For neonates: Erythromycin base or ethylsuccinate 50 mg/kg/day divided into four doses daily for 14 days 1
- No evidence supports adding topical therapy to systemic treatment 4, 1
- Re-evaluate following treatment, as treatment failure rates can reach 19% 4
- Treat sexual partners simultaneously and evaluate for concomitant sexually transmitted diseases 4
- Consider sexual abuse in children with chlamydial conjunctivitis 4, 2
MRSA Conjunctivitis
- MRSA infections may require compounded topical vancomycin, as MRSA organisms are resistant to many commercially available topical antibiotics including aminoglycosides 1
- Bacterial resistance is an increasing concern, particularly with MRSA 1, 5
Neonatal Conjunctivitis (Birth to 28 Days)
Neonatal conjunctivitis always requires immediate treatment and evaluation due to risk of serious complications including corneal perforation, septicemia, and meningitis. 5
- Hospitalization is mandatory for neonatal conjunctivitis 1
- Gonococcal conjunctivitis (manifests 1-7 days after birth) requires systemic ceftriaxone 125 mg IM plus topical antibiotics 5
Viral Conjunctivitis
Viral conjunctivitis requires supportive treatment only; avoid prescribing antibiotics as this promotes unnecessary costs and antibiotic resistance. 1, 6
Allergic Conjunctivitis
Allergic conjunctivitis is treated with topical antihistamines and mast cell stabilizers; itching is the most consistent diagnostic sign. 6
- Treatment options include:
Mandatory Ophthalmology Referral Criteria
Refer to an ophthalmologist immediately for any of the following: 4, 1
- Visual loss 4, 1
- Moderate or severe pain 4, 1
- Severe purulent discharge 4, 1
- Corneal involvement or infiltrates 4, 1, 5
- Conjunctival scarring 4
- Lack of response to therapy after 3-4 days 4, 1
- Recurrent episodes 4
- History of HSV eye disease 4
- History of immunocompromise 4
- All contact lens wearers with conjunctivitis due to higher risk of complications 2
Infection Control and Patient Education
- Hand washing is critical to reduce transmission risk 4, 5
- Avoid sharing towels, pillows, and close contact during contagious period 2
- Patients should not wear contact lenses if signs or symptoms of bacterial conjunctivitis are present 4, 3
- Return to school or work is generally permitted once treatment has been initiated for 24 hours and symptoms begin to improve 5, 2
Common Pitfalls to Avoid
- Do not prescribe antibiotics for viral conjunctivitis, which promotes resistance and unnecessary costs 1
- Do not use topical antibiotics alone for gonococcal or chlamydial conjunctivitis—systemic therapy is mandatory 1, 2
- Do not overlook the possibility of sexual abuse in children with gonococcal or chlamydial infections 4, 2
- Do not use fluoroquinolones as first-line for mild cases—reserve for severe infections to minimize resistance 1
- In neonatal intensive care settings, gram-negative conjunctivitis is often resistant to gentamicin 1